Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...
Gottlieb was commissioner of the Food and Drug Administration from 2017 to 2019. When Makena, a drug designed to prevent preterm births, hit the market in 2011 at $1,500 per dose, it drew rife ...
If you’ve received medication through popular telemedicine companies like Hims & Hers Health, you’re probably familiar with drug compounding. That’s the process of creating customized medicine for a ...
On May 1, the US Food and Drug Administration (FDA) announced that it is proposing to exclude semaglutide, tirzepatide, and liraglutide from the ...
Compounding drugs prior to receipt of a valid prescription. Compounding drugs removed from the market for safety reasons. Compounding drugs that are essentially copies of commercially available ...
The US Food and Drug Administration (FDA) has announced the release of four guidance documents intended to help increase regulatory oversight of the pharmaceutical compounding industry. The documents ...
As part of the implementation of 2013’s Drug Quality and Security Act (DQSA), the US Food and Drug Administration (FDA) on Friday released draft guidance explaining how it will formulate a list of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results